Latest Strategic Partnership News

Global Health Limited reports a robust 23% increase in customer receipts and an 85% jump in quarterly operating cashflow, as it advances its transition to AI-enabled SaaS platforms targeting profitability by June 2026.

Dreadnought Resources reports a 36% increase in high-grade gold resources at Star of Mangaroon, secures $18 million in funding, and advances critical metals projects with promising drilling results and strategic partnerships.

Alicanto Minerals Limited has announced a 12-for-1 consolidation of its securities, including ordinary shares, performance rights, and options, effective from late January 2026. This move will significantly reduce the number of securities on issue and adjust option exercise prices accordingly.

Peako Limited has intensified its exploration efforts in the East Kimberley region, targeting multiple mineral commodities while implementing prudent cash flow measures including director remuneration deferrals.

Zelira Therapeutics has raised nearly US$33 million from ThirdGate Capital to advance its HOPE® 1 drug targeting autism-related Phelan-McDermid Syndrome through FDA clinical trials. This funding milestone sets the stage for pivotal regulatory progress in the US.

Orthocell has increased its investment in Marine Biomedical to 11.7%, securing exclusive distribution rights to the innovative PearlBone™ technology as it nears FDA approval.

Talga Group reports significant high-grade gallium and other critical elements from surface sampling at its Aero Project in Sweden, highlighting the site's growing strategic importance amid rising global demand for technology metals.

4DMedical Limited has raised $150 million through a well-supported institutional placement to accelerate the commercialisation of its innovative lung imaging product CT – VQ™ in the US market. The capital raise comes with minimal dilution and increased insider confidence.

Victory Metals reports breakthrough metallurgical results at North Stanmore, slashing rare earth leach times and boosting critical mineral grades, while advancing strategic ties with Sumitomo and U.S. advisors.

Amaero Ltd has lowered its FY2026 revenue guidance due to delayed U.S. government contracts but reports strong contracted revenue and a robust cash position heading into 2026.

Vitrafy Life Sciences has entered a 12-month exclusive partnership with IMV Technologies to integrate cryopreservation technologies, securing up to A$930k in fees and milestone payments.

Vitrafy Life Sciences has secured a 12-month exclusive partnership with global animal reproduction leader IMV Technologies to co-develop and commercialise next-generation cryopreservation solutions for farm animals and aquaculture.